SCHEMBL7988063

SCHEMBL7988063

BCC(=O)c1ccc(F)c(F)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.59
CES1 P23141 2/20 0.59
MAOA P21397 2/20 0.42
MAOB P27338 2/20 0.42
KMT2A Q03164 2/20 0.42
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
MEN1 O00255 1/20 0.42
CHRNA1 P02708 1/20 0.41
CHRNG P07510 1/20 0.41
CHRNB1 P11230 1/20 0.41
CHRNB2 P17787 1/20 0.41
SLC6A2 P23975 1/20 0.41
CHRNB4 P30926 1/20 0.41
CHRNA3 P32297 1/20 0.41
CHRNA4 P43681 1/20 0.41
SLC6A3 Q01959 1/20 0.41
CHRND Q07001 1/20 0.41
DPP4 P27487 1/20 0.40
PLA2G7 Q13093 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12877455 0.84 CES2 (0.41) CES2CES1KMT2ARAB9ANPC1
SCHEMBL12021922 0.84 CES2 (0.41) CES2CES1MAOAMAOBKMT2A
SCHEMBL14684053 0.82 HDAC1 (0.56) CES2CES1KMT2AKCNQ3KCNQ2
SCHEMBL5253742 0.81 CES2 (0.61) CES2CES1MAOAMAOBKMT2A
SCHEMBL2273688 0.81 CES2 (0.61) CES2CES1MAOAMAOBKMT2A
SCHEMBL30255233 0.81 CES2 (0.61) CES2CES1MAOAMAOBKMT2A
SCHEMBL671907 0.81 CES2 (0.61) CES2CES1MAOAMAOBKMT2A
SCHEMBL10066834 0.80 AR (0.40) CES2CES1KMT2ARAB9ANPC1
SCHEMBL633278 0.79 CES2 (0.59) CES2CES1KMT2AMEN1CHRNA1
SCHEMBL247898 0.79 CES2 (0.59) CES2CES1KMT2ARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009129109-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-10-22 WO disclosed